Search results
Novo Nordisk under Senate probe over Wegovy pricing
Seeking Alpha· 7 days agoA key Senate committee on Wednesday announced an investigation into Novo Nordisk's (NVO) pricing of weight loss drug semaglutide in the US. Read more...
Sanders takes aim at US drug prices of Novo’s Ozempic and Wegovy
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe letter said the committee is investigating future reductions of the list and net prices of both...
Bernie Sanders slams pharma giant for ‘outrageously high prices’ of Ozempic and Wegovy — says it...
Moneywise via AOL· 4 days agoHe concluded his letter to Jørgensen with a simple question: “Will Novo Nordisk substantially reduce...
Should You Invest in Novo Nordisk (NVO) Ahead of Q1 Earnings?
Zacks· 2 days agoRevenue growth in the first quarter of 2024 is expected to have been driven by strong demand for Novo Nordisk’s diabetes and obesity care medicines, especially ...
Sanders launches Senate investigation into ‘outrageously high’ pricing of Ozempic, Wegovy
KEYT 3 Santa Barbara· 7 days agoThe Vermont senator, an independent who has long called out drug manufacturers for their costly...
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY via Yahoo Finance· 6 days agoSanders added that if Novo Nordisk's prices for these drugs are not substantially reduced, "They...
Sanders launches investigation into ‘unacceptable’ diabetes, weight loss drug prices
The Hill via Yahoo News· 7 days agoSanders penned a letter Wednesday to Novo Nordisk CEO Lars Fruergaard Jørgensen notifying him...
How one state is trying to make weight loss drugs cheaper
NBC Universal via AOL· 7 days agoWeight loss drugs aren't covered by insurance for North Carolina's state employees. The state is...
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
CNBC· 7 days agoThe U.S. Senate has launched an investigation into the high price of Novo Nordisk's popular weight...
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 1 day agoThe Federal Trade Commission is challenging hundreds of alleged “junk” patent listings filed by...